Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huayu (Wuxi) Pharmaceutical Co., Ltd. is a China-based pharmaceutical company specializing in the development and manufacturing of chemical drugs, with a particular focus on chronic disease treatments. Founded in 2002 and headquartered in Wuxi, the company has established itself as a key player in the cardiovascular and metabolic therapeutic areas. Huayu is well-regarded for its advanced drug delivery technologies, specifically in the formulation of sustained-release and controlled-release oral medications. Their product portfolio includes widely prescribed generics such as metformin and amlodipine, produced in GMP-certified facilities. The company continues to expand its reach through both domestic sales and international exports, aiming to provide affordable and effective healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huayu (Wuxi) Pharmaceutical.